Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 4/20 | 0.68 |
| ▸ | CTSK | P43235 | 4/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | KLK7 | P49862 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL478905 | 1.00 | CTSS (0.68) | CTSSCTSKTSHRCA2LMNA | |
| SCHEMBL4395744 | 1.00 | CTSS (0.68) | CTSSCTSKTSHRCA2LMNA | |
| SCHEMBL1486229 | 1.00 | CTSS (0.68) | CTSSCTSKTSHRCA2LMNA | |
| Methanesulfonamide SCHEMBL6898028 | 0.92 | CTSS (0.60) | CTSSCTSKTSHRCA2LMNA | |
| Methanesulfonamide SCHEMBL6777577 | 0.92 | CTSS (0.60) | CTSSCTSKTSHRCA2LMNA | |
| SCHEMBL2118282 | 0.90 | CTSK (0.56) | CTSSCTSKTSHRCA2PPARG | |
| SCHEMBL2118283 | 0.90 | CTSK (0.56) | CTSSCTSKTSHRCA2PPARG | |
| SCHEMBL7874195 | 0.89 | CTSS (0.57) | CTSSCTSKTSHRCA2LMNA | |
| SCHEMBL7874192 | 0.89 | CTSS (0.57) | CTSSCTSKTSHRCA2LMNA | |
| SCHEMBL16715127 | 0.89 | CTSK (0.56) | CTSSCTSKTSHRCA2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 854 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136948-A | Cycloastragal derivative with activity of resisting methicillin-resistant staphylococcus aureus and preparation method thereof | 山西医科大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119528812-B | Double amino acid-genipin derivative and preparation method and application thereof | 广东工业大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119775353-A | Short peptide compound and preparation method thereof, cosmetic composition and application | 常州市智态生创科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119528812-A | Double amino acid-genipin derivative and preparation method and application thereof | 广东工业大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119118908-A | Rhein nitroxide free radical derivative and synthetic method and application thereof | 甘肃中医药大学 | 2024-12-13 | — | — | CN | claimed |
| CN-116425649-B | Amino acid-curcumin derivative and preparation method and application thereof | 八叶草生物科技(三明)有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-116987148-B | Synthesis process of acetyl hexapeptide-8 | 山东济肽生物科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118085005-A | 18 Beta-glycyrrhetinic acid derivative and preparation method and application thereof | 石河子大学 | 2024-05-28 | — | — | CN | claimed |
| CN-111825742-B | Polypeptide solid phase synthesis of CTPA as special coupling agent for amino acid ionic liquid | 陈铭 | 2024-01-30 | — | — | CN | claimed |
| CN-117304131-A | Alpha-carbonyl alkenyl ester compound, and preparation method and application thereof | 广州医科大学 | 2023-12-29 | — | — | CN | claimed |
| US-6951946-B2 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. (US) | 2005-10-04 | — | — | US | claimed |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | KOLB HARTMUTH C (US) | 2005-07-14 | — | — | US | claimed |
| US-20050020650-A1 | 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof | DONG WHA PHARM. CO., LTD. (KR) | 2005-01-27 | — | — | US | claimed |
| EP-1451163-A4 | 3-AMIDO-1,2-BENZOISOXAZOLE DERIVATIVES, PROCESS FOR PREPARATION, AND USE THEREOF | DONG WHA PHARM IND CO LTD (KR) | 2005-01-26 | — | — | EP | claimed |
| EP-1451163-A1 | 3-AMIDO-1,2-BENZOISOXAZOLE DERIVATIVES, PROCESS FOR PREPARATION, AND USE THEREOF | DONG WHA PHARMACEUTICAL INDUSTRIAL CO. LTD. (KR) | 2004-09-01 | — | — | EP | claimed |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| WO-2003040113-A1 | 3-AMIDO-1,2-BENZOISOXAZOLE DERIVATIVES, PROCESS FOR PREPARATION, AND USE THEREOF | DONG WHA PHARM. IND. CO., LTD. (KR) | 2003-05-15 | — | — | WO | claimed |
| US-5763647-A | THROMBOXANE A2 RECEPTOR ANTAGONISTS | SHIONOGI & CO., LTD. (JP) | 1998-06-09 | — | — | US | claimed |
| EP-0452000-B1 | Preparation of optically active norbornyl amine derivatives | SHIONOGI & CO (JP) | 1995-10-18 | — | — | EP | claimed |
| EP-0452000-A2 | Preparation of optically active norbornyl amine derivatives | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1991-10-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020650-A1 | 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof | LTB4R, FPR1, LTB4R2 | CTSS 518/4885CTSK 461/4885TSHR 816/4885 |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | CTSS 2627/4885CTSK 2356/4885TSHR 4013/4885 |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | CTSS 2627/4885CTSK 2356/4885TSHR 4013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.